Log on / register
Feedback | Support | My details

Pre-publication history

Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor

Jennifer P Montgomery email and Paul H Patterson email

BMC Cancer 2008, 8:354doi:10.1186/1471-2407-8-354

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript14 Nov 2007
Reviewer's ReportHassan Fathallah-Shaykh30 Jan 2008
Reviewer's ReportMarc Sanson03 Mar 2008
Resubmission - Version 2ManuscriptAuthors' comments02 Apr 2008
Reviewer's ReportHassan Fathallah-Shaykh01 May 2008
Reviewer's ReportMarc Sanson18 May 2008
Reviewer's ReportTetsu Akiyama04 Oct 2008
Resubmission - Version 3ManuscriptAuthors' comments23 Oct 2008
Resubmission - Version 5Manuscript17 Nov 2008
Resubmission - Version 6Manuscript19 Nov 2008
Resubmission - Version 7ManuscriptAuthors' comments25 Nov 2008
Resubmission - Version 8Manuscript27 Nov 2008
Accepted28 Nov 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.